A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer

NCT00038584 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell
Cancer of Head and Neck

Interventions

DRUG: SCH66336

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]